T HE BASILAR ARTERY (BA) IS the largest artery in the posterior circulation and forms the central core of this vascular territory. It is most commonly affected by atherosclerosis, and necropsy studies have found it to be one of the first and most severely involved of all intracranial arteries. 1 The BA is also affected by embolism, dissections, aneurysms, migraine, and inflammatory conditions. 2 Despite the wide range of underlying pathologic features, BA occlusive disease is an uncommon cause of stroke. Most reports have retrospectively described isolated cases or small series of patients. [3] [4] [5] [6] [7] [8] [9] [10] Early reports were based on necropsy studies that emphasized clinicoanatomical correlations rather than the underlying vascular lesion, correlating focal brain lesions with symptoms and signs found during life. [4] [5] [6] 11 Until recently, premortem diagnosis of posterior circulation vascular lesions required invasive techniques, such as catheter angiography, a procedure often not performed because it was considered risky and unnecessary to guide therapy. Consequently, many series included only select patients and did not reflect the true spectrum of disease. [7] [8] [9] [10] Now new treatment options, such as thrombolysis and angioplasty and noninvasive diagnostic imaging techniques promote premortem diagnosis of BA occlusive disease. However, still few prospective studies are available, [12] [13] [14] [15] and disparities remain regarding the natural history, underlying stroke mechanisms, vascular features, and prognosis of BA occlusive disease. We herein report an analysis of patients with moderate to severe stenosis or occlusion of the BA in the New England Medical Center Posterior Circulation Registry (NEMC-PCR), the largest prospective series of consecutively collected patients with posterior circulation ischemia to date.
METHODS

THE NEMC-PCR
The patients analyzed herein were identified among 407 patients collected consecutively in the NEMC-PCR between January 1, 1988 , and December 31, 1996. Detailed inclusion criteria and characteristics of this registry have been previously described. 13 Briefly, the NEMC-PCR is a prospective database of patients with symptomatic vertebrobasilar territory ischemia. All patients were evaluated at the New England Medical Center in Boston, Mass, by 1 of 3 stroke neurologists (L.R.C., L.D.D., or M.S.P.). Detailed information on clinical symptoms and signs, neurologic examination, stroke risk factors, hospital course, and outcome was recorded. All patients in the registry with a diagnosis of moderate (50%-70%) to severe (Ͼ70%) BA stenosis or occlusion were included in the analysis. The BA lesions were documented by magnetic resonance angiography, catheter angiography, or transcranial Doppler. Infarct location was determined by computed tomography and magnetic resonance imaging using standard axial sequences (T1, T2, and fluid-attenuated inversion recovery). Patients with dolichoectatic BA were excluded if there were no signs of atherothrombosis.
DETERMINATION OF STROKE MECHANISMS
Stroke mechanisms were determined according to previously described criteria. 1 3 Large artery occlusive diseasehemodynamic mechanism required demonstration of severe stenosis or occlusion of the vertebral arteries, BA, or posterior cerebral arteries (PCAs) with infarction in the respective territories supplied by these arteries. Cardioembolism was diagnosed when infarction within the territory of multiple, superficial, or single large arteries occurred and an embolic cardiac source was identified. Artery-to-artery embolism was defined as the presence of a severely stenosed or occluded proximal artery with evidence of infarction distal to the occlusive vascular lesion. Branch penetrator disease was diagnosed when infarction was limited to the territory of the penetrating branch(es) without large artery involvement or a cardioembolic source.
DISTRIBUTION OF INFARCTS
We used a previously published classification 16 that divides the intracranial vertebrobasilar territory into 3 levels according to its rostral-caudal distribution to describe the localization of brain infarctions. The levels and arteries included are shown in the Figure. The proximal posterior circulation territory is fed by the intracranial vertebral arteries (ICVAs) and their posteroinferior cerebellar artery branches and includes the medulla and the posteroinferior cerebellum. The middle posterior circulation territory includes the BA up to its superior cerebellar artery branches and the anteroinferior cerebellar arteries and their pontine and anteroinferior cerebellar artery-cerebellar supply zones. The superior cerebellar arteries, the penetrating distal branches of the BA, and the PCAs, in addition to their midbrain, thalamic, superior cerebellar artery-cerebellar, temporal, and occipital lobe supply zones, constitute the distal posterior circulation territory. When patients had infarcts in more than 1 territory, they were classified in combined groups: proximal and middle; proximal and distal; middle and distal; and proximal, middle, and distal.
BA DISEASE GROUPS
Patients were divided into 3 groups. In group A, stenosis or occlusion of the BA was due to intrinsic and isolated disease, usually atherosclerosis, often with superimposed thrombus formation. This included patients in whom thrombosis of the BA was thought to have originated in and propagated from an ICVA. In group B, BA disease was part of severe and extensive atherosclerosis with additional, often multiple, atherosclerotic sites within the posterior circulation. Group C included patients who had embolism to the BA from the heart or vertebral arteries.
STATISTICAL ANALYSIS
Differences in demographic, vascular, and clinical characteristics between groups were compared by univariate analysis, using the t test for age and the 2 test for all categorical variables. To examine the association of predictor variables and the risk of poor outcome (defined as death or major disability), we determined relative risks (RRs) and their corresponding 95% confidence intervals (CIs). All statistical analyses were performed using Sigmastat version 2.0.3 (Sigmastat Corp, SPSS Inc, Chicago, Ill). total number of patients in the registry. Ages ranged from 5 to 87 years (mean, 61.2 years). Women were, on average, older than men; half of the women were older than 70 years, compared with 22% of the men (P = .008). Seventy-six patients (87.4%) were white, 7 (8.0%) were of Asian descent, and 2 (2.3%) were African American. The demographic characteristics of the study population are shown in Table 1 .
RESULTS
DEMOGRAPHY
BA DISEASE GROUPS
Most patients (39 [44.8%]) belonged to group A and had isolated, intrinsic BA stenosis or occlusion, including 2 patients in whom the BA atherothrombosis originated and propagated from an ICVA. Slightly fewer BA lesions (36 [41.4%]) were due to BA occlusive disease as part of extensive posterior circulation atherosclerosis (group B). The 12 patients (13.8%) in group C had embolism to the BA from the heart or vertebral arteries. patients with embolism to the BA had no or 1 risk factor (P = .03). The only 2 patients who used oral contraceptives had cardioembolism, a 29-year-old smoker and user of illicit drugs who had atrial fibrillation and an 18-year-old patient who had a large atrial septal defect. Among patients with a cardiac embolic source, 6 (75%) of 8 had 1 risk factor or none. Only 1 patient in this subgroup had several risk factors. A 68-year-old patient who smoked had hypertension, hyperlipidemia, and coronary artery disease; a left ventricular akinetic segment; and a thrombus noted in the left ventricle on echocardiography. When excluding this patient, hypertension, smoking, and use of oral Abbreviations: CAD, coronary artery disease; PVD, peripheral vascular disease. *Values are expressed as number (percentage) of patients unless otherwise indicated. For an explanation of the 3 groups, see the "BA Disease Groups" subsection of the "Methods" section.
RISK FACTORS
†Percentages calculated among women.
contraceptives were the only risk factors associated with cardioembolic BA disease.
CLINICAL COURSE
The course of the BA occlusive disease among groups is shown in Table 3 . Two thirds of patients (58 of 87) initially had TIAs, of whom 34 (58.6%) progressed to stroke. The most common clinical course among patients with intrinsic, localized BA or multivessel disease was TIA followed by stroke (32/75 [42.7%]). Except for 2 patients, embolism to the BA was associated with sudden-onset stroke without preceding TIAs (10 patients [83.3%]). These 2 patients had TIAs that preceded strokes by an average of 1.2 months. One was the 18-year-old woman with a large atrial septal defect described earlier; she had a TIA 10 days before the stroke. The other was a 20-yearold man with a small patent foramen ovale with an interatrial shunt; he had progressively frequent and symptomatic TIAs in the 2 months preceding the stroke. Among patients in groups A and B, the frequency of ischemia patterns was similar, with TIAs followed by stroke predominating in both groups. The TIAs occurred for months and even years in some patients (Table 3 ) and were usually multiple and increased in frequency as the stroke approached. When excluding 4 patients (3 from group A, 1 from group B) with TIAs occurring across 5 years, the average period of occurrence of TIAs was 2.1 months for patients with isolated BA disease and 7.8 months for patients with multivessel disease. Three patients with widespread atherosclerotic disease continued having TIAs after the stroke. 
SYMPTOMS AND SIGNS
STROKE MECHANISM
The most common mechanism underlying BA territory ischemia was, by far, hemodynamic associated with large artery occlusive disease (65 patients [74.7%]) ( Table 5) .
When excluding patients with BA embolism, this mechanism accounted for 65 (86.7%) of the ischemic events. The remaining stroke mechanisms in groups A and B were artery-to-artery embolism secondary to BA dissection (3 patients), branch artery occlusive disease (3 patients), basilar migraine (2 patients), coagulopathy (1 patient), and unknown (1 patient). Among the 12 patients with embolism to the BA, 8 had a cardiac source. Congenital heart lesions were the underlying source in 4 patients. A 5-yearold boy had cyanotic congenital heart disease due to an atrial septal defect and pulmonary atresia. Atrial septal defect was present in 2 other patients and patent foramen ovale in 1 patient; these patients were aged 18, 42, and 20 years, respectively. Two patients had atrial fibrillation, secondary to thyrotoxicosis in a 29-year-old woman and chronic in an 87-year-old man. One patient had an atrial septal aneurysm and 1, a left ventricular akinetic segment with a mural thrombus. None of these individuals had a potential proximal arterial source of embolism. Two patients had intra-arterial embolism, 1 from a severe extracranial vertebral artery (ECVA) occlusion and 1 from bilateral ICVA occlusive disease. Neither had a potential cardiac embolic source. One patient had both a large, dyskinetic ventricular segment and an ECVA occlusion. No embolic source was identified in 1 individual.
SEVERITY AND DISTRIBUTION OF BA LESIONS
Fifty-five (63.2%) of 87 patients had moderate or severe BA stenosis, and 32 (36.8%) of 87 patients had BA occlusion ( had involvement of the middle third, of whom 9 (56.3%) also had proximal lesions and 5 (31.3%) had distal lesions. All 3 BA segments were affected in only 2 patients. Among patients with embolism to the BA, 10 (83.3%) had a single lesion, half of these localized to the distal segment. Both patients with lesions affecting multiple segments had middle and distal BA involvement. group also had internal carotid artery disease, which was moderate to severe in 9 patients (25.0%) and occluded in 2 (5.6%). Among patients with BA stenosis, 75.0% of other affected arteries were stenotic and 25.0% occluded, while among BA occlusion patients, 80.0% of other affected arteries were also occluded (PϽ.001), showing a significant association in severity of atherosclerosis between posterior circulation arteries.
ADDITIONAL POSTERIOR CIRCULATION INVOLVEMENT (GROUP B)
DISTRIBUTION OF INFARCTS
Localization of infarcts within posterior circulation territories is shown in Table 8 . Ischemia distribution varied substantially according to the BA group. Most patients with isolated or multivessel BA occlusive disease had involvement of the middle territory alone or in combination with other territories (33 [84.6%] and 26 [72.2%], respectively). Distal territory was involved in 21 patients (53.8%) in group A and the proximal territory in 20 patients (55.6%) in group B. Basilar artery embolism predominantly affected the distal territory (8 patients [66.7%]), either alone (8 patients [66.7%]) or combined with the middle territory (4 patients [33.3%]). Involvement of multiple intracranial territories was more common in group B (22 [61.1%]), whereas in 21 patients (53.8%) with isolated intrinsic BA lesions and 8 patients (66.7%) with embolism to the BA, only 1 territory was affected. When patients with only TIAs and reversible deficits were included, involvement of the medial and distal territories, either alone or combined, accounted for 43 (68.3%) of 63 patients. Overall, the middle posterior circulation territory including the pons and the anteroinferior cerebellum was most often affected (66/87 [75.9%]), followed by the distal territory supplied by the rostral BA, superior cerebellar arteries, and PCAs (44/87 [50.6%]) and the proximal segment, which includes the medulla and posteroinferior cerebellum (26/87 [29.9%]). Among 26 individuals with proximal territory infarcts, only 4 had no ICVA occlusive lesion. One of these patients had migraine with extensive BA vasoconstriction, 1 had coagulopathy secondary to AIDS, and 2 had ECVA occlusions. OUTCOME Table 9 shows outcomes at hospital discharge. The mortality rate was surprisingly low; only 2 patients (2.3%) died, 1 in group B because of cerebrovascular disease and 1 in group A from other causes. Overall, 25 patients (28.7%) died or were left with a major deficit. Outcome was the best in patients with widespread atherosclerosis, with 30 (83.3%) having no or only minor disability at hospital discharge, whereas 30 [69.2%] of 39 patients with isolated BA occlusive disease had favorable outcomes. The worst outcomes occurred in group C; although there were no deaths, 7 (58.3%) individuals had major deficits and only 5 (41.7%) had minor or no deficits. This represented a 2.4-fold higher risk of poor outcome in patients with BA embolism compared with patients with diffuse or localized atherosclerosis (58.3% vs 24%; RR, 2.43; 95% CI, 1.30-4.54; P =.03). Even when patients with only TIAs and reversible deficits were excluded from the analysis, overall, 38 (60.3%) of 63 individuals had a good outcome.
When considering clinical symptoms and signs, decreased level of consciousness, tetraparesis or tetraplegia, and pupillary abnormalities were significantly associated with worse outcome. Among the 25 patients who faired poorly, 11 (44%) had a reduced level of consciousness compared with 5 patients (8.1%) among those who had minor or no disability; this yielded a 3.5-fold increase in risk of poor outcome (RR, 3.49; 95% CI, 1.96-6.19; PϽ.001). Three patients with poor outcome (12%) and 1 patient (1.6%) who had a minor deficit all initially had pupillary abnormalities, showing a trend toward worse outcome in patients with abnormal pupils (RR, 2.93; 95% CI, 1.49-5.75; P=.06). All patients who had tetraparesis had poor outcomes (RR, 4.1; 95% CI, 2.8-6.0; P=.001); 1 patient died and 4 had major disabilities.
Among patients with posterior circulation ischemia due to isolated or multivessel BA atherosclerosis, we analyzed outcome as a function of BA lesion severity and found that patients with BA occlusion had a significantly higher risk of poor outcome than individuals with BA stenosis (40% vs 16%; RR, 2.5; 95% CI, 1.13-5.54; P=.02). When we included patients with BA embolism *Values are expressed as number (percentage) of patients. For an explanation of the 3 groups, see the "BA Disease Groups" subsection of the "Methods" section. in this analysis, there was still a trend toward a higher risk of poor outcome associated with occlusions (40.6% vs 21.8%; RR, 1.86; 95% CI, 0.97-3.58; P = .06), even though this was the only group in which occlusions predominated over stenoses, even among patients with favorable outcomes.
We further analyzed outcome stratified by region of infarction. Table 10 presents poor outcome as a function of the posterior circulation territory involved. Involvement of the middle and distal territories alone or combined accounted for 21 poor outcomes (84.0%) (death or major disability) and 100% in the group with BA embolism. All patients who had only the proximal territory affected had favorable outcomes. Among patients with involvement of the middle or distal territories (alone or associated with other territories), 38 (35.0%) of 110 patients had poor outcomes. Involvement of the distal territory was associated with a more than 2-fold increase in the risk of death or major disability (RR, 2.08; 95% CI, 1.0-4.3; P=.04). Risk estimates for the proximal and proximal and middle regions combined could not be calculated accurately because of the small number of patients.
COMMENT
Following the landmark report of Kubik and Adams, 4 necropsy, imaging, and angiographic studies have attempted to define the common clinical and pathologic features of BA occlusive disease. Our report of 87 patients with moderate to severe BA stenosis or occlusion collected consecutively in the NEMC-PCR is, to our knowledge, the largest prospective series to date of BA occlusive disease collected before death. The previous largest prospective studies include the follow-up analysis of 44 patients with basilar and distal vertebral artery stenosis reported by Moufarrij et al, 17 the Mehler 15 description of 61 patients with rostral BA syndrome, and the report from Bogousslavsky et al 17 of 70 patients with infarcts in the posterior circulation from the Lausanne Stroke Registry, 27 of whom had BA stenosis or occlusion.
The incidence of BA occlusive disease has not been determined because of selection bias and diverse inclusion criteria used in most reports. We found that approximately one fourth of patients in the NEMC-PCR had some degree of BA involvement, of which the majority (87/109 [79.8%]) was moderate to severe or occluded. This frequency lies within the range previously described in most necropsy-or angiography-based reports. In the necropsy study of Castaigne et al, 11 18 BA occlusions were identified among 44 patients (41%) with posterior circulation infarcts. In the Lausanne Stroke Registry, magnetic resonance angiography showed 27 cases of BA stenosis or occlusion among 70 consecutive patients (39%) with posterior circulation strokes 17 ; only patients older than 45 years who had magnetic resonance imaging results that showed lesions appropriate to the clinical syndrome were included. In a recent follow-up of this registry, only 43 patients (1.8%) had documentation of BA occlusive disease among 2332 patients with posterior circulation ischemia admitted consecutively during a 10-year period. In the Joint Study of Extracranial Arterial Occlusions, an arteriographic study of patients with extracranial artery disease, BA stenosis was identified in only 292 (7.7%) and occlusion in 303 (0.8%) of 3788 patients. 18 We described 3 distinct groups of patients that were relatively homogeneous with respect to risk factors, etiology, clinical course, symptoms and signs, localization of the BA lesion, infarct distribution, and outcome. Previous inconsistent data in the literature regarding these characteristics may be owing to the inclusion of variable numbers of patients belonging to these different groups. The largest group (group A) consisted of patients with isolated occlusive BA disease, caused mostly by atherosclerosis, as well as a small number of nonatherosclerotic etiologies. This group made up 44.8% of cases of BA disease in the NEMC-PCR. The prevalence of vascular risk factors was high, and the middle segment of the artery, with the corresponding posterior circulation territory, was most frequently involved. Twenty-nine of these patients initially had TIAs followed in 20 by strokes. Bulbar and pseudobulbar symptoms were present in about 31 patients (80.0%), and more than half (20/39) had hemiparesis or hemiplegia, whereas tetraparesis was infre- patients in group C had the worst outcomes. Furthermore, patients with embolic lesions to the BA have less time to develop collateral circulation. Accordingly, patients with BA stenosis are at lower risk of severe outcomes compared with those with BA occlusion. Decreased level of consciousness, tetraparesis, and abnormal pupils were identified as clinical predictors of poor outcome. Although these clinical signs were less frequent than previously described, their presence increased the probability of major disability or death 3-to 4-fold. Devuyst et al 14 recently found that decreased consciousness was the single most powerful prognostic factor in BA disease, followed by pupillary disorders, bulbar signs, and dysarthria.
Analysis of this large series of patients contributes to understanding the spectrum of BA occlusive disease and clarifies previous controversies. We described 3 distinct groups of patients with different vascular, clinical, etiological, and prognostic characteristics. A large group of patients, previously underemphasized, who had BA disease as part of widespread posterior circulation atherosclerosis had surprisingly good prognoses. We found several predictive factors of poor outcome. Early identification of these factors in patients and their inclusion into 1 of the BA groups may guide diagnostic evaluation and rational treatment.
